Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The closing price of Candel Therapeutics Inc (NASDAQ: CADL) was $5.33 for the day, down -1.66% from the previous closing price of $5.42. In other words, the price has decreased by -$1.66 from its previous closing price. On the day, 0.73 million shares were traded. CADL stock price reached its highest trading level at $5.51 during the session, while it also had its lowest trading level at $5.2626.
Ratios:
Our analysis of CADL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.04 and its Current Ratio is at 7.04. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.01.
On February 20, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $25.Citigroup initiated its Buy rating on February 20, 2025, with a $25 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 28 ’25 when Nichols William Garrett sold 937 shares for $6.98 per share. The transaction valued at 6,540 led to the insider holds 52,493 shares of the business.
Nichols William Garrett sold 781 shares of CADL for $3,936 on Jun 30 ’25. The Chief Medical Officer now owns 52,493 shares after completing the transaction at $5.04 per share. On Jun 30 ’25, another insider, WILLIAM GARRETT NICHOLS, who serves as the Officer of the company, bought 3,593 shares for $4.90 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CADL now has a Market Capitalization of 292590880 and an Enterprise Value of 200244880.
Stock Price History:
The Beta on a monthly basis for CADL is -0.93, which has changed by -0.08732879 over the last 52 weeks, in comparison to a change of 0.13837254 over the same period for the S&P500. Over the past 52 weeks, CADL has reached a high of $14.60, while it has fallen to a 52-week low of $3.79. The 50-Day Moving Average of the stock is -4.06%, while the 200-Day Moving Average is calculated to be -15.63%.
Shares Statistics:
CADL traded an average of 784.38K shares per day over the past three months and 1049290 shares per day over the past ten days. A total of 54.89M shares are outstanding, with a floating share count of 37.78M. Insiders hold about 31.18% of the company’s shares, while institutions hold 37.50% stake in the company. Shares short for CADL as of 1759190400 were 7222409 with a Short Ratio of 9.21, compared to 1756425600 on 7270816. Therefore, it implies a Short% of Shares Outstanding of 7222409 and a Short% of Float of 16.620001000000002.
Earnings Estimates
The company has 2 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.28, with high estimates of -$0.23 and low estimates of -$0.33.
Analysts are recommending an EPS of between -$0.77 and -$0.77 for the fiscal current year, implying an average EPS of -$0.77. EPS for the following year is -$0.46, with 1.0 analysts recommending between -$0.46 and -$0.46.
